聚集蛋白对脓毒症大鼠骨骼肌烟碱型乙酰胆碱受体亚型异化表达的影响

吕碧霄; 闵苏; 杨俊

doi:10.16016/j.1000-5404.201812109

您当前的位置：

首页 >

文章列表页 >

聚集蛋白对脓毒症大鼠骨骼肌烟碱型乙酰胆碱受体亚型异化表达的影响

基础医学 | 更新时间：2026-01-09

- 聚集蛋白对脓毒症大鼠骨骼肌烟碱型乙酰胆碱受体亚型异化表达的影响
- Agrin reduces heterogenous expression of nicotinic acetylcholine receptors in skeletal muscles of septic rats
- 第三军医大学学报 2019年41卷第12期页码：1125-1130, 1135
- 作者机构：
  
  400016 重庆, 重庆医科大学附属第一医院麻醉科
- 作者简介：
  
  [闵苏，E-mail:ms89011068@163.com MIN Su, E-mail: ms89011068@163.com
- 基金信息：
  
  国家自然科学基金面上项目(81471282)
- DOI：10.16016/j.1000-5404.201812109
  中图分类号： R337.4;R341;R631
- 收稿：2018-12-13，
  
  修回：2019-02-15，
  
  纸质出版：2019-06-30
- 稿件说明：
移动端阅览
吕碧霄, 闵苏, 杨俊. 聚集蛋白对脓毒症大鼠骨骼肌烟碱型乙酰胆碱受体亚型异化表达的影响[J]. 第三军医大学学报, 2019,41(12):1125-1130, 1135.

Bixiao LYU, Su MIN, Jun YANG. Agrin reduces heterogenous expression of nicotinic acetylcholine receptors in skeletal muscles of septic rats[J]. Journal of Third Military Medical University, 2019, 41(12): 1125-1130, 1135.
吕碧霄, 闵苏, 杨俊. 聚集蛋白对脓毒症大鼠骨骼肌烟碱型乙酰胆碱受体亚型异化表达的影响[J]. 第三军医大学学报, 2019,41(12):1125-1130, 1135. DOI： 10.16016/j.1000-5404.201812109.

Bixiao LYU, Su MIN, Jun YANG. Agrin reduces heterogenous expression of nicotinic acetylcholine receptors in skeletal muscles of septic rats[J]. Journal of Third Military Medical University, 2019, 41(12): 1125-1130, 1135. DOI： 10.16016/j.1000-5404.201812109.

摘要

目的

探讨聚集蛋白(agrin)对脓毒症大鼠骨骼肌烟碱型乙酰胆碱受体(nicotinic acetylcholine receptor

nAChR)亚型异化表达的作用。

方法

采用盲肠结扎穿孔(cecal ligation and puncture

CLP)建立脓毒症大鼠模型。48只2月龄健康雄性SD大鼠采用随机数字表法分为假手术组(Sham组)、假手术+agrin组(ShamA组)、脓毒症组(CLP组)和脓毒症+agrin组(CLPA组)，每组12只。假手术组仅暴露腹腔不进行盲肠结扎穿孔手术，ShamA组和CLPA组在建模后胫前肌内注射100 μg/mL agrin溶液0.1 mL。建模后第48小时取大鼠血液样品，检测血浆中炎症因子IL-6水平。行复合肌动作电位(compound muscle action potential

CMAP)检测其振幅、时程、潜伏期及神经传导速度。Western blot和免疫荧光检测大鼠胫前肌组织γ-nAChR和α7-nAChR蛋白表达。

结果

Sham组和ShamA组血浆IL-6水平明显低于CLP组和CLPA组(

0.05)。与Sham组和ShamA组比较，CLP组与CLPA组CMAP时程、潜伏期延长(

0.05)，γ-nAChR和α7-nAChR蛋白表达升高(

0.05)，而CMAP振幅及传导速度降低(

0.05)。与CLP组比较，CLPA组的CMAP时程、潜伏期缩短(

0.05)，γ-nAChR和α7-nAChR蛋白表达降低(

0.05)，而CMAP振幅及传导速度升高(

0.05)。

结论

Agrin可以减轻脓毒症导致的神经肌肉功能障碍并减少异质化烟碱型乙酰胆碱受体的表达。

Abstract

Objective

To explore the effect of agrin on the heterogenous expression of nicotinic acetylcholine receptors (nAChRs) in the skeletal muscles of rats with sepsis.

Methods

Forty-eight 2-month-old healthy SD rats were randomized equally into sham-operated group

sham+agrin group (ShamA group)

cecal ligation and puncture (CLP) group

and CLP+agrin group (CLPA group) and received either CLP to establish models of sepsis or a sham operation of laparotomy without CLP as indicated. In ShamA group and CLPA group

the rats were given an intramuscular injection of 0.1 mL agrin (100 μg/mL) into the anterior tibial muscle after the operation. At 48 h after the modeling

blood samples were collected from the rats for measurement of plasma interleukin-6 (IL-6) level

and the compound muscle action potentials (CMAP) were detected to assess the neuromuscular conduction. The protein expression levels of type γ-nAChR and α7-nAChR in the anterior tibial muscle were detected using Western blotting and immunofluorescence staining.

Results

The plasma IL-6 levels were significantly lower in the sham-operated and ShamA group than in CLP and CLPA groups (

0.05) and were comparable between the latter 2 groups (

0.05). Compared with those in the 2 sham-operated groups

the duration and latency of CMAP were increased significantly while the amplitude and nerve conduction velocity were decreased obviously in CLP group (

0.05). Compared with those in CLP group

the duration and latency of CMAP were decreased and the amplitude and nerve conduction velocity were increased significantly in CLPA group (

0.05). In the anterior tibial muscle

the protein expression levels of γ-nAChR and α7-nAChR were significantly higher in CLP and CLPA groups than in the 2 sham-operated groups (

0.05)

and their levels were the highest in CLP group (

0.05).

Conclusion

Agrin can improve neuromuscular function in rats with sepsis

which is likely attributed to down-regulated heterogeneous expression of γ-nAChR and α7-nAChR in the skeletal muscles.

关键词

Keywords

references

HERMANS G, VAN DEN BERGHE G. Clinical review: intensive care unit acquired weakness[J]. Crit Care, 2015, 19: 274. DOI: 10.1186/s13054-015-0993-7.

HUND E. Neurological complications of sepsis: critical illness polyneuropathy and myopathy[J]. J Neurol, 2001, 248(11): 929-934.

MARTYN J A, FAGERLUND M J, ERIKSSON L I. Basic principles of neuromuscular transmission[J]. Anaesthesia, 2009, 64(Suppl 1): 1-9. DOI: 10.1111/j.1365-2044.2008.05865.x.

XIE F, MIN S, CHEN J Y, et al. Ulinastatin inhibited sepsis-induced spinal inflammation to alleviate peripheral neuromuscular dysfunction in an experimental rat model of neuromyopathy[J]. J Neurochem, 2017, 143(2): 225-235. DOI: 10.1111/jnc.14145.

LIU L, XIE F, WEI K, et al. Sepsis induced denervation-like changes at the neuromuscular junction[J]. J Surg Res, 2016, 200(2): 523-532. DOI: 10.1016/j.jss.2015.09.012.

BEZAKOVA G, RUEGG M A. New insights into the roles of agrin[J]. Nat Rev Mol Cell Biol, 2003, 4(4): 295-308. DOI: 10.1038/nrm1074.

RIMER M, MATHIESEN I, LØMO T, et al. Gamma-AChR/epsilon-AChR switch at agrin-induced postsynaptic-like apparatus in skeletal muscle[J]. Mol Cell Neurosci, 1997, 9(4): 254-263.

EBRAHIMI M, OSTROVIDOV S, SALEHI S, et al. Enhanced skeletal muscle formation on microfluidic spun gelatin methacryloyl (GelMA) fibres using surface patterning and agrin treatment[J]. J Tissue Eng Regen Med, 2018, 12(11): 2151-2163. DOI: 10.1002/term.2738.

SINGER M, DEUTSCHMAN C S, SEYMOUR C W, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. DOI: 10.1001/jama.2016.0287.

RITTIRSCH D, HUBER-LANG M S, FLIERL M A, et al. Immunodesign of experimental sepsis by cecal ligation and puncture[J]. Nat Protoc, 2009, 4(1): 31-36. DOI: 10.1038/nprot.2008.214.

XIE F, ZHANG F, MIN S, et al. Glial cell line-derived neurotrophic factor (GDNF) attenuates the peripheral neuromuscular dysfunction without inhibiting the activation of spinal microglia/monocyte[J]. BMC Geriatr, 2018, 18(1): 110. DOI: 10.1186/s12877-018-0796-1.

CANKAYALI I, DOGAN Y H, SOLAK I, et al. Neuromuscular deterioration in the early stage of sepsis in rats[J]. Crit Care, 2007, 11(1): R1. DOI: 10.1186/cc5139.

RUDOLF R, KHAN M M, LABEIT S, et al. Degeneration of neuromuscular junction in age and dystrophy[J]. Front Aging Neurosci, 2014, 6: 99. DOI: 10.3389/fnagi.2014.00099.

JONSSON FAGERLUND M, DABROWSKI M, ERIKSSON L I. Pharmacological characteristics of the inhibition of nondepolarizing neuromuscular blocking agents at human adult muscle nicotinic acetylcholine receptor[J]. Anesthesiology, 2009, 110(6): 1244-1252. DOI: 10.1097/ALN.0b013e31819fade3.

BEZAKOVA G, HELM J P, FRANCOLINI M, et al. Effects of purified recombinant neural and muscle agrin on skeletal muscle fibers in vivo [J ] . J Cell Biol, 2001, 153(7): 1441-1452.

BASSAT E, MUTLAK Y E, GENZELINAKH A, et al. The extracellular matrix protein agrin promotes heart regeneration in mice[J]. Nature, 2017, 547(7662): 179-184. DOI: 10.1038/nature22978.

GASPERI C, MELMS A, SCHOSER B, et al. Anti-agrin autoantibodies in myasthenia gravis[J]. Neurology, 2014, 82(22): 1976-1983. DOI: 10.1212/WNL.0000000000000478.

OHNO K, OHKAWARA B, ITO M. Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders[J]. Expert Opin Ther Tar, 2017, 21(10): 949-958. DOI: 10.1080/14728222.2017.1369960.

BARIK A, ZHANG B, SOHAL G S, et al. Crosstalk between agrin and wnt signaling pathways in development of vertebrate neuromuscular junction[J]. Dev Neurobiol, 2014, 74(8): 828-838. DOI: 10.1002/dneu.22190.

YANG X, ARBER S, WILLIAM C, et al. Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation[J]. Neuron, 2001, 30(2): 399-410.

WANG X, MIN S, XIE F, et al. Glial cell-derived neurotrophic factor alleviates sepsis-induced neuromuscular dysfunction by decreasing the expression of γ- and α7-nicotinic acetylcholine receptors in an experimental rat model of neuromyopathy[J]. Biochem Biophys Res Commun, 2018, 496(2): 260-266. DOI: 10.1016/j.bbrc.2018.01.020.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

线粒体预处理周细胞对脓毒症大鼠肺血管渗漏的保护作用

左旋肉碱对脓毒症心肌收缩功能障碍的改善作用及机制

PD-1介导的CD4⁺T细胞耗竭加剧脓毒症小鼠的肠道菌群异位

ATF3通过抑制ATG5和ATG16L1表达调控巨噬细胞自噬与炎症反应

瑞马唑仑对脓毒症小鼠肠道屏障功能的保护作用